6.1.1.2: Intermediate and long-acting insulins

Part of chapter 6 Endocrine System, section 6.1 Drugs used in diabetes

High-level prescribing trends for Intermediate and long-acting insulins (BNF section 6.1.1.2) across Newport Health Centre for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Biphasic insulin aspart (0601012W0)
Biphasic insulin lispro (0601012F0)
Biphasic isophane insulin (0601012D0)
Insulin degludec (0601012Z0)
Insulin detemir (0601012X0)
Insulin glargine (0601012V0)
Insulin glargine/lixisenatide (0601012AB)
Insulin zinc suspension (0601012G0)
Isophane insulin (0601012S0)
Protamine zinc insulin (0601012U0)
Feedback